Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
60.05 |
43.73 |
26.55 |
21.21 |
16.98 |
Secured loans
18.66 |
7.52 |
8.79 |
9.10 |
6.08 |
Unsecured loans
Total
81.80 |
54.34 |
38.43 |
33.40 |
26.15 |
Gross block
16.17 |
14.81 |
13.93 |
11.36 |
10.86 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
10.70 |
9.99 |
9.40 |
7.19 |
6.86 |
Capital work-in-progress
Investments
Current assets, loans & advances
103.57 |
74.62 |
47.99 |
50.08 |
33.36 |
Less : current liabilities & provisions
34.35 |
30.27 |
18.97 |
24.95 |
14.08 |
Total net current assets
69.22 |
44.35 |
29.03 |
25.13 |
19.29 |
Miscellaneous expenses not written
Total
81.80 |
54.34 |
38.43 |
33.40 |
26.15 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
30.90 |
30.90 |
30.90 |
30.90 |
30.90 |